ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,475.09
      0.27%
      US Tech 100
      19,276.80
      0.00%
      Dow Jones
      39,169.52
      0.13%
      Brent Oil
      86.535
      0.01%
      Bitcoin
      62,567.93
      -0.45%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Sana Biotechnology Inc (SANA)

      7. Sana Biotechnology Inc (SANA) News

      SANA

      Sana Biotechnology (SANA)

      Sana Biotechnology Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:SANA
      DateTimeSourceHeadlineSymbolCompany
      12/01/20234:05PMGlobeNewswire Inc.Sana Biotechnology Publishes Early Clinical Data Showing that SC291, a CD19-directed Allogeneic CAR T Therapy, Evades Immune Detection in Presence of Intact Immune SystemNASDAQ:SANASana Biotechnology Inc
      11/27/20237:01PMPR Newswire (US)Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science LeadersNASDAQ:SANASana Biotechnology Inc
      11/21/20239:00AMGlobeNewswire Inc.Sana Biotechnology to Present at November and December 2023 Investor ConferencesNASDAQ:SANASana Biotechnology Inc
      11/21/20236:00AMPR Newswire (US)Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of GeneticsNASDAQ:SANASana Biotechnology Inc
      11/17/20239:00AMGlobeNewswire Inc.Uppsala University Hospital and Sana Biotechnology Announce Authorization of the First-in-Human Clinical Trial Application for a Primary Islet Cell Treatment for Patients with Type 1 DiabetesNASDAQ:SANASana Biotechnology Inc
      11/09/20234:05PMGlobeNewswire Inc.Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-directed Allogeneic CAR T Therapy, for Patients with Lupus Nephritis, Extrarenal Lupus, and ANCA-associated VasculitisNASDAQ:SANASana Biotechnology Inc
      11/08/20234:24PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SANASana Biotechnology Inc
      11/08/20234:14PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SANASana Biotechnology Inc
      11/08/20234:05PMGlobeNewswire Inc.Sana Biotechnology Reports Third Quarter 2023 Financial Results and Business UpdatesNASDAQ:SANASana Biotechnology Inc
      11/03/20234:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SANASana Biotechnology Inc
      11/03/20234:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SANASana Biotechnology Inc
      11/02/20239:05AMGlobeNewswire Inc.Sana Biotechnology Announces Five Presentations at the 65th American Society of Hematology Annual MeetingNASDAQ:SANASana Biotechnology Inc
      11/01/202310:30AMPR Newswire (US)Flagship Pioneering Launches Pioneering IntelligenceNASDAQ:SANASana Biotechnology Inc
      10/10/20234:21PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SANASana Biotechnology Inc
      10/10/20234:15PMGlobeNewswire Inc.Sana Biotechnology Announces Increased Focus on Hypoimmune-Related Pipeline with the Potential to Deliver Clinical Proof of Concept Data from Four Programs in 2023 and 2024 with a 2024 Operating Burn under $200MNASDAQ:SANASana Biotechnology Inc
      09/13/20236:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SANASana Biotechnology Inc
      09/11/20236:30AMPR Newswire (US)Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development OfficerNASDAQ:SANASana Biotechnology Inc
      08/30/20234:05PMGlobeNewswire Inc.Sana Biotechnology to Present at September 2023 Investor ConferencesNASDAQ:SANASana Biotechnology Inc
      08/29/20239:00AMPR Newswire (US)Invaio achieves first registration for citrus greening solution featuring Trecise™ technologyNASDAQ:SANASana Biotechnology Inc
      08/21/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SANASana Biotechnology Inc
      08/03/20234:23PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SANASana Biotechnology Inc
      08/03/20234:14PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SANASana Biotechnology Inc
      08/03/20234:05PMGlobeNewswire Inc.Sana Biotechnology Reports Second Quarter 2023 Financial Results and Business UpdatesNASDAQ:SANASana Biotechnology Inc
      06/16/20239:00AMGlobeNewswire Inc.Sana Biotechnology Highlights Preclinical Data from Hypoimmune and Fusogen Platforms at the International Society for Stem Cell Research (ISSCR) 2023 Annual MeetingNASDAQ:SANASana Biotechnology Inc
      06/09/20234:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SANASana Biotechnology Inc
      06/09/20234:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SANASana Biotechnology Inc
      06/09/20234:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SANASana Biotechnology Inc
      06/09/20234:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SANASana Biotechnology Inc
      06/09/20234:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SANASana Biotechnology Inc
      06/09/20234:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SANASana Biotechnology Inc
       Showing the most relevant articles for your search:NASDAQ:SANA